MERCORELLI, BEATRICE

MERCORELLI, BEATRICE  

Dipartimento di Medicina Molecolare - DMM  

Mostra records
Risultati 1 - 20 di 41 (tempo di esecuzione: 0.041 secondi).
Titolo Data di pubblicazione Autori Rivista Serie Titolo libro
4,6-Diphenylpyridines as Promising Novel Anti-Influenza Agents Targeting the PA-PB1 Protein-Protein Interaction: Structure-Activity Relationships Exploration with the Aid of Molecular Modeling 2016 NANNETTI, GIULIOMERCORELLI, BEATRICEPALU', GIORGIOLOREGIAN, ARIANNA + JOURNAL OF MEDICINAL CHEMISTRY - -
A 6-Aminoquinolone Compound, WC5, with Potent and Selective Anti-Human Cytomegalovirus Activity 2009 MERCORELLI, BEATRICEMURATORE, GIULIASINIGALIA, ELISABIASOLO, MARIA-ANGELAPALU', GIORGIOLOREGIAN, ARIANNA + ANTIMICROBIAL AGENTS AND CHEMOTHERAPY - -
A Broad anti-influenza hybrid small molecule that potently disrupts the interaction of polymerase acidic protein-basic protein 1 (PA-PB1) subunits 2015 NANNETTI, GIULIOMURATORE, GIULIAMERCORELLI, BEATRICEPALU', GIORGIOLOREGIAN, ARIANNA + JOURNAL OF MEDICINAL CHEMISTRY - -
A novel small-molecule inhibitor of the human papillomavirus E6-p53 interaction that reactivates p53 function and blocks cancer cells growth 2020 Celegato M.Messa L.Mercorelli B.Bertagnin C.Palu G.Loregian A. + CANCER LETTERS - -
A point mutation in a herpesvirus polymerase determines neuropathogenicity. 2007 LOREGIAN, ARIANNAMERCORELLI, BEATRICEPALU', GIORGIO + PLOS PATHOGENS - -
A quantitative LumiFluo assay to test inhibitory compounds blocking p53 degradation induced by human papillomavirus oncoprotein E6 in living cells 2018 Messa, LorenzoCelegato, MartaBertagnin, ChiaraMercorelli, BeatriceNannetti, GiulioPalù, GiorgioLoregian, Arianna SCIENTIFIC REPORTS - -
A small molecule targeting the interaction between human papillomavirus E7 oncoprotein and cellular phosphatase PTPN14 exerts antitumoral activity in cervical cancer cells 2023 Bertagnin C.Celegato M.Sturlese M.Mercorelli B.Moro S.Loregian A. + CANCER LETTERS - -
Antiviral strategies against influenza virus: towards new therapeutic approaches. 2014 LOREGIAN, ARIANNAMERCORELLI, BEATRICENANNETTI, GIULIOCOMPAGNIN, CHIARAPALU', GIORGIO CELLULAR AND MOLECULAR LIFE SCIENCES - -
Approaches for the generation of new anti-cytomegalovirus agents: identification of protein-protein interaction inhibitors and compounds against the HCMV IE2 protein. 2014 MERCORELLI, BEATRICEPALU', GIORGIOLOREGIAN, ARIANNA + - METHODS IN MOLECULAR BIOLOGY Human Cytomegaloviruses
Binding parameters and thermodynamics of the interaction of the human cytomegalovirus DNA polymerase accessory protein, UL44, with DNA: implications for the processivity mechanism 2007 LOREGIAN, ARIANNASINIGALIA, ELISAMERCORELLI, BEATRICEPALU', GIORGIO + NUCLEIC ACIDS RESEARCH - -
Caratterizzazione di nuovi composti antivirali contro il citomegalovirus umano e studio del meccanismo di neuropatogenocità nel herpesvirus equino di tipo 1 2009 Mercorelli, Beatrice - - -
Composition and methods for the treatment of pathological condition associated with cytomegalovirus infection. 2010 LOREGIAN, ARIANNAPALU', GIORGIOMERCORELLI, BEATRICE + - - -
Design, synthesis, and biological evaluation of first-in-class indomethacin-based PROTACs degrading SARS-CoV-2 main protease and with broad-spectrum antiviral activity 2024 Desantis, JennyBazzacco, AlessandroTuci, SaraMercorelli, BeatriceLoregian, Arianna + EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY - -
Design, Synthesis, and Biological Evaluation of Trisubstituted Piperazine Derivatives as Noncovalent Severe Acute Respiratory Syndrome Coronavirus 2 Main Protease Inhibitors with Improved Antiviral Activity and Favorable Druggability 2023 Mercorelli B.Loregian A. + JOURNAL OF MEDICINAL CHEMISTRY - -
Design, synthesis, and evaluation of WC5 analogues as inhibitors of human cytomegalovirus Immediate-Early 2 protein, a promising target for anti-HCMV treatment. 2013 MERCORELLI, BEATRICEPALU', GIORGIOLOREGIAN, ARIANNA + CHEMMEDCHEM - -
Discovery of novel SARS-CoV-2 inhibitors targeting the main protease Mpro by virtual screenings and hit optimization 2022 Mercorelli, BeatriceDesantis, JennyCelegato, MartaBazzacco, AlessandroLoregian, Arianna + ANTIVIRAL RESEARCH - -
Divide et impera: An In Silico Screening Targeting HCMV ppUL44 Processivity Factor Homodimerization Identifies Small Molecules Inhibiting Viral Replication 2021 Ghassabian, HaniehTimmoneri, MMercorelli, BLoregian, APalu, GAlvisi, G + VIRUSES - -
Drug Repurposing Approach Identifies Inhibitors of the Prototypic Viral Transcription Factor IE2 that Block Human Cytomegalovirus Replication 2016 MERCORELLI, BEATRICENANNETTI, GIULIOPALU', GIORGIOLOREGIAN, ARIANNA + CELL CHEMICAL BIOLOGY - -
Drug Repurposing Campaigns for Human Cytomegalovirus Identify a Natural Compound Targeting the Immediate-Early 2 (IE2) Protein: A Comment on "The Natural Flavonoid Compound Deguelin Inhibits HCMV Lytic Replication within Fibroblasts" 2019 Mercorelli, BeatricePalù, GiorgioGribaudo, GiorgioLoregian, Arianna + VIRUSES - -
Drug Repurposing for Viral Infectious Diseases: How Far Are We? 2018 Mercorelli, BeatricePalù, GiorgioLoregian, Arianna TRENDS IN MICROBIOLOGY - -